Regional Impact Report: Global Fund’s Investments in the Pacific Region. The Global Fund. (2019)

immage

The Global Fund is partnering with governments, medical experts, advocates, civil society and communities affected by HIV, TB and malaria to fight the three diseases and build resilient and sustainable systems for health. As of May 2019, the Global Fund partnership has invested a total of US$366 million in 14 island countries in the Pacific region.

 

Keywords: HIV, TB, treatment, investment, women, girls

 

 

Download Publication
 

Country Impact Report: India. The Global Fund. (2019)

immage

India is a strategic partner of the Global Fund, both as an implementer and a donor. The government of India has shown great leadership in improving the health needs of its citizens and fighting infectious diseases, especially tuberculosis. India has ambitious goals for all three diseases, including ending TB by 2025 – five years ahead of the Sustainable Development Goals. Since 2002, the Global Fund has disbursed US$2.1 billion in programs to fight HIV, TB and malaria and strengthen health systems in India.


Keywords: HIV, TB, EMTCT, treatment, investment

 

Download Publication

STEP UP THE FIGHT: Focus on Building Resilient and Sustainable Systems for Health. The Global Fund. (2019)

immage

Robust health systems are not only essential to ending HIV, TB and malaria as epidemics, they yield broader health outcomes, delivering health services in a sustainable, equitable and effective way. Resilient and sustainable systems for health are necessary for accelerating progress toward universal health coverage, and help countries prepare for emerging threats to global health security.

 

Keywords: HIV, TB, UHC, investment, community


 

Download Publication

STEP UP THE FIGHT: Focus on Global Health Security. The Global Fund. (2019)

immage

Microbes do not stop at national borders, so an infectious disease threat anywhere is a threat everywhere. Making our world safer from epidemics means strengthening the capacity of countries to prevent, detect and respond effectively to current and emerging health threats.

 


Keywords: HIV, TB, drug-resistant, surveillance, funding

 

 

Download Publication

FOCUS ON: Drug-resistant Tuberculosis. The Global Fund. (2019)

immage

Drug-resistant TB is part of the growing challenge of antimicrobial-resistant superbugs that do not respond to existing medications, resulting in fewer treatment options and increasing mortality rates for illnesses that would ordinarily be curable – including TB. Global development partners must move faster to contain this threat of antimicrobial resistance (AMR) before it escalates to claim millions of lives around the world.


Keywords: TB, drug-resistant, treatment, diagnostic, health system

 

 

Download Publication

FOCUS ON: The Crucial Role of Communities: Strengthening Responses to HIV, Tuberculosis and Malaria. The Global Fund. (2018)

immage

Community voices and leadership in governance, implementation and oversight of Global Fund-supported programs is essential to achieving lasting impact.

Lessons from the Ebola response and the transition to the Sustainable Development Goals, with the specific target of achieving universal health coverage, have spurred the Global Fund to reflect on how people access health services and how countries respond to health crises. Rethinking our approaches to building resilient and sustainable systems for health will be essential in order to maximize equitable access and impact on HIV, TB and malaria.


Keywords: HIV, TB, health system, community, responses

 

Download Publication

FACTSHEET on HARiS - HIV and AIDS Response Indicator Survey 2018 for Men who have Sex with Men. Centre for Health Protection, Department of Health, Hong Kong. (2019)

immage

Men who have sex with men (MSM) has continued to account for a significant proportion of newly acquired HIV infections in Hong Kong. To keep on tracking the epidemic and inform intervention, MSM population has been included as one of the five major at-risk populations in the HIV/AIDS Response Indicator Survey (HARiS).

 


Keywords: HIV, MSM, testing, counselling and testing (VCT)

 

 

Download Factsheet

FACTSHEET on HARiS - HIV and AIDS Response Indicator Survey 2018 for Male-to-female Transgender. Centre for Health Protection, Department of Health, Hong Kong. (2019)

immage

Male-to-female transgender (TG) has been a neglected and hard-to-reach community, yet various overseas studies have shown that their HIV prevalence can be quite high. To better study the situation in Hong Kong, it has been included as one distinct at-risk populations in the HIV/AIDS Response Indicator Survey (HARiS) since 2014.

 

 

Keywords: HIV, STI, transgender, condom use, testing

 

 

Download Factsheet

FACTSHEET on HARiS - HIV and AIDS Response Indicator Survey 2018 for Injecting Drug User. Centre for Health Protection, Department of Health, Hong Kong. (2019)

immage

In Hong Kong, the number of HIV cases transmitted through injecting drug use (IDU) has remained low up till now and contributed to less than 5% of all reported cases cumulatively. However, the potential risk of cluster outbreak and rapid upsurge of infection among the IDU population is always a concern. To monitor HIV-related risk behaviours and access to HIV testing services among IDU, this population has been included as one of the four at-risk populations in the HIV/AIDS Response Indicator Survey (HARiS) implemented since 2013. The sixth round of survey was conducted in 2018 via commissioning to the Stanley Ho Centre for Emerging Infectious Disease, School of Public Health and Primary Care of the Chinese University of Hong Kong.

 

Keywords: HIV, IDU, drug, testing, condom use, needle

 

Download Factsheet

FACTSHEET on HIV/AIDS Situation in Hong Kong 2018. Centre for Health Protection, Department of Health, Hong Kong. (2019)

immage

The first case of HIV infection in Hong Kong was reported in 1984. As of 2018, the Department of Health has received a cumulative total of 9,715 reports of HIV infection and 1,996 AIDS cases under the voluntary and anonymous HIV/AIDS reporting system. The number of HIV reports in 2018 was 624, 8% decrease compared to the 681 cases in 2017. People infected with HIV progress to AIDS when they suffer from clinical complications of severe immunodeficiency due to HIV. In 2018, 139 AIDS reports were received. The most common illnesses presenting at AIDS were Pneumocystis pneumonia and tuberculosis.

 

Keywords: HIV, AIDS, IDU, drug, testing, condom use, needle

 

Download Factsheet

Pages

Data Dashboard
database
Highlighted publications
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/PNG_HIV_National_Strategic_Information_2018-22.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/PNG_National_STI_and_HIV_Strategy.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS-young-peoples-participation-in-community-based-responses-to-hiv_2019.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/UNODC_factsheet_Ending_AIDS_by_2030_for_people_and_with_PUD_2018.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_GAP_progress_report_2019.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/HRI-women-harm-reduction-2018.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Elective_C-section_should_not_be_routinely_recommended_to_WLHIV_2018.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/ESCAP_Asia_and_the_Pacific_SDG_Progress_Report_2019.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guideline_on_digital_interventions_for_health_system_strengthening_2019.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Progress_report_on_HIV_viral_hepatitis_and_STI_2019.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_HIV_UHC_Guide_Civil_Society_2019.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/NSACP_Sri_Lanka_Annual_Report_2018.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_HIV-related-travel-restrictions-explainer_2019.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/HIV-and-the-Law-supplement-2018.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/Myanmar_IBBS_and_Population_size_estimates_among_PWID_2017-2018.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/Myanmar_IBBS_and_Population_size_estimates_among_MSM_2015.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/Myanmar_IBBS_and_Population_size_estimates_among_FSW_2015.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Global_TB_Report_2018.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/Nepal_National_Community_Led_HIV_Testing_Guidelines_2018.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_IBBS_PWID_PWUD_2017.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_IBBS_FEW_2017.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/DataHub_TB-HIV_Fact_Sheet_2018.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/NSACP_Sri_Lanka_National_HIV_Communication_Strategy_2017.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_Status_of_National_AIDS_Response_2017.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V1_North-East_region_2017.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V2_West_South_region_2017.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V3_Northern_Central_Eastern_region_2017.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_Annual_report_2016-17.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guidelines_for_Managing_Advanced_HIV_Disease_and_Rapid_Initiation_of_ART_2017.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_Estimations_and_projections_of_HIV_AIDS_at_Sub-national_level_2016-2020.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_HIV_drug_resistance_report_2017.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guidelines_on_public_health_response_to_pretreatment_HIV_drug_resistance_2017.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/Myanmar_National_Strategic_Plan_on_HIV_and_AIDS_2016-2020.pdf
Calendar of events
Sep
17
(17 Sep - 17 Sep)
Oct
11
Nov
14